
Tenofovir + Emtricitabine
300/200mg
Tenofovir and emtricitabine are combined in a tablet for HIV infection and pre-exposure prophylaxis. It is supplied in a single strength; pack sizes vary. Each option lists its price per tablet.
Pre-exposure prophylaxis, usually shortened to PrEP, is a daily antiretroviral regimen for people who do not have HIV but are at substantial risk of acquiring it. Consistent use reduces the chance of HIV transmission through sex by around 99%. The regimen combines two antiretroviral medicines in one tablet.

300/200mg
Tenofovir and emtricitabine are combined in a tablet for HIV infection and pre-exposure prophylaxis. It is supplied in a single strength; pack sizes vary. Each option lists its price per tablet.
Tenofovir and emtricitabine are taken together once a day. Both block the reverse transcriptase enzyme that HIV needs in order to copy itself inside human cells. Having the drugs in the body before contact with the virus is what prevents infection from taking hold.
PrEP is indicated for HIV-negative adults in higher-risk groups. These include people who inject drugs, serodiscordant couples where one partner has HIV, and men who have sex with men. Starting requires a confirmed negative HIV test.
PrEP belongs within a wider approach to HIV management. It is typically used with condom use, screening for other sexually transmitted infections, and HIV testing every three months.
Tenofovir + Emtricitabine 300/200mg tablets carry both ingredients in a single daily dose. Pharmacy partners in India ship orders to Malaysia in discreet packaging.
Last updated